300573 兴齐眼药
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)34.71520.59414.80714.61519.214
总资产报酬率 ROA (%)26.34216.28612.61112.20214.680
投入资产回报率 ROIC (%)31.48418.84814.35713.97317.469

边际利润分析
销售毛利率 (%)81.32878.33177.37378.74478.087
营业利润率 (%)36.95221.85618.84220.01124.165
息税前利润/营业总收入 (%)36.38620.37717.63218.05224.289
净利润/营业总收入 (%)31.46017.39516.35616.93720.343

收益指标分析
经营活动净收益/利润总额(%)99.878101.116101.219100.82097.623
价值变动净收益/利润总额(%)0.000-0.0060.0000.0001.291
营业外收支净额/利润总额(%)-2.134-7.523-4.350-7.010-1.994

偿债能力分析
流动比率 (X)1.8961.7983.4805.6753.689
速动比率 (X)1.5511.4662.9574.8733.343
资产负债率 (%)23.23625.12116.49912.93620.295
带息债务/全部投入资本 (%)3.5968.0330.670-3.9782.864
股东权益/带息债务 (%)2,592.0001,094.71614,211.811-2,488.6923,211.526
股东权益/负债合计 (%)330.374298.081506.080673.062392.723
利息保障倍数 (X)177.057406.238-41.567-27.88540.711

营运能力分析
应收账款周转天数 (天)39.73338.82136.97833.42538.588
存货周转天数 (天)123.611123.797140.014145.398128.372